We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





AI-Powered COVID-19 Cough Analyzer App Assesses Respiratory Health and Associated Risks

By LabMedica International staff writers
Posted on 28 Aug 2020
Print article
Image: kAs (Photo courtesy of Zensark Technologies)
Image: kAs (Photo courtesy of Zensark Technologies)
A team of scientists have repurposed an artificial intelligence/machine learning-powered cough analysis mobile app for assessing respiratory health and associated COVID-19 risks.

The mobile app called kAs has been developed by Zensark Technologies (Hyderabad, Telangana, India), in collaboration with Salcit Technologies (Hyderabad, Telangana, India), to assess respiratory health of the patients by leveraging machine learning and disease specific cough signatures. It brings the functionality of Spirometry using one's smartphone to carry out on demand assessments without the need to step out of the house. Patients can use their mobile phones to track the sound of their cough to assess and track their health.

The app has been developed based on the guidelines laid out by the WHO and asks 15 questions to the subject. The subject then cough into the mobile app which sends the cough sounds to the company’s AI platform Swaasa, where it undergoes an audiometric analysis and produces a composite COVID Risk Score, based on the answers to the questionnaire and the coughing sound. The app generates a rating on a scale of 1 to 10, with 10 being the highest risk level. The Risk Score of any individual can be tracked across multiple days or weeks. The subjects can be asked to submit cough samples as many times a day for as many days as necessary. Based on the samples and symptoms, the app tracks the risk level of each individual over time.

Anytime a subject is found to be breaching a threshold risk score, it is highlighted to public health officials on their dashboards. The dashboards are designed to show the population level statistics and can drill down to the detailed reports of an individual subject. The app also allows doctors, with an external microphone and wireless stethoscope to track various breathing and risk parameters.

Related Links:
Zensark Technologies
Salcit Technologies


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.